Literature DB >> 9492277

Ionisation behaviour and solution properties of the potassium-channel blocker ShK toxin.

J E Tudor1, M W Pennington, R S Norton.   

Abstract

The effects of pH, temperature and polypeptide concentration on the solution structure and side chain interactions of ShK toxin, a potassium-channel-blocking polypeptide from the sea anemone Stichodactyla helianthus, have been investigated by means of one-dimensional and two-dimensional 1H-NMR spectroscopy. Resonance assignments have been obtained for most protons in the molecule, and for the alpha and beta carbon atoms. The lack of concentration dependence of the 1H chemical shifts and linewidths indicates that self-association is not significant and cannot account for the sheet-like structure near the N terminus. The structure is stable to high temperature, showing little change even at 353 K. This stability allowed backbone-amide temperature coefficients to be interpreted, and the correlation of these values with hydrogen bonds observed in the structures and with solvent exchange rates is discussed. pKa values have been measured for Asp5, His19 and Tyr23, and the contributions to these pKa values from other residues investigated using the analogues R11Q (denoting substitution of Argll with Gln), R11E, H19K, K22A, Y23A and K30A. These results show that Asp5 (pKa 2.8) makes an electrostatic interaction with Lys30, which may be partially responsible for the importance of these side chains in the folding of synthetic toxin. The phenolic pKa of Tyr23 is reduced to 8.7 in the native toxin, as a result of interactions with the positively charged side chains of Arg11 and to a lesser extent Lys22. Several hydrogen bonds between the Arg11 guanidino group and the Tyr23 phenolic group are found in the solution structures. As these three residues are implicated in the tight binding of ShK toxin to the T-lymphocyte voltage-gated potassium channel Kv1.3, their close interactions should be taken into account in models of binding of this toxin to the pore and vestibule of this and other potassium channels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9492277     DOI: 10.1046/j.1432-1327.1998.2510133.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

Review 1.  Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

Authors:  Victor Chi; Michael W Pennington; Raymond S Norton; Eric J Tarcha; Luz M Londono; Brian Sims-Fahey; Sanjeev K Upadhyay; Jonathan T Lakey; Shawn Iadonato; Heike Wulff; Christine Beeton; K George Chandy
Journal:  Toxicon       Date:  2011-08-12       Impact factor: 3.033

2.  Reinvestigation of the biological activity of d-allo-ShK protein.

Authors:  Bobo Dang; Sandeep Chhabra; Michael W Pennington; Raymond S Norton; Stephen B H Kent
Journal:  J Biol Chem       Date:  2017-06-08       Impact factor: 5.157

3.  Conformational flexibility in the binding surface of the potassium channel blocker ShK.

Authors:  Inbal Sher; Shih Chieh Chang; Ying Li; Sandeep Chhabra; Arthur G Palmer; Raymond S Norton; Jordan H Chill
Journal:  Chembiochem       Date:  2014-09-18       Impact factor: 3.164

Review 4.  Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases.

Authors:  Christine Beeton; Michael W Pennington; Raymond S Norton
Journal:  Inflamm Allergy Drug Targets       Date:  2011-10

5.  Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.

Authors:  Shih Chieh Chang; Charles A Galea; Eleanor W W Leung; Rajeev B Tajhya; Christine Beeton; Michael W Pennington; Raymond S Norton
Journal:  Toxicon       Date:  2012-05-31       Impact factor: 3.033

6.  Potassium channel modulation by a toxin domain in matrix metalloprotease 23.

Authors:  Srikant Rangaraju; Keith K Khoo; Zhi-Ping Feng; George Crossley; Daniel Nugent; Ilya Khaytin; Victor Chi; Cory Pham; Peter Calabresi; Michael W Pennington; Raymond S Norton; K George Chandy
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

7.  A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.

Authors:  Michael W Pennington; M Harunur Rashid; Rajeev B Tajhya; Christine Beeton; Serdar Kuyucak; Raymond S Norton
Journal:  FEBS Lett       Date:  2012-10-09       Impact factor: 4.124

Review 8.  Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking.

Authors:  Charles A Galea; Hai M Nguyen; K George Chandy; Brian J Smith; Raymond S Norton
Journal:  Cell Mol Life Sci       Date:  2013-08-03       Impact factor: 9.261

9.  Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases.

Authors:  Sandeep Chhabra; Shih Chieh Chang; Hai M Nguyen; Redwan Huq; Mark R Tanner; Luz M Londono; Rosendo Estrada; Vikas Dhawan; Satendra Chauhan; Sanjeev K Upadhyay; Mariel Gindin; Peter J Hotez; Jesus G Valenzuela; Biswaranjan Mohanty; James D Swarbrick; Heike Wulff; Shawn P Iadonato; George A Gutman; Christine Beeton; Michael W Pennington; Raymond S Norton; K George Chandy
Journal:  FASEB J       Date:  2014-06-02       Impact factor: 5.191

10.  A potent and selective peptide blocker of the Kv1.3 channel: prediction from free-energy simulations and experimental confirmation.

Authors:  M Harunur Rashid; Germano Heinzelmann; Redwan Huq; Rajeev B Tajhya; Shih Chieh Chang; Sandeep Chhabra; Michael W Pennington; Christine Beeton; Raymond S Norton; Serdar Kuyucak
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.